MS Research Australia recently collaborated with the MS ACT/NSW/VIC in the first of a series of MS Researcher

MS Research Australia is delighted to announce that nearly $1.9 million in funding has been awarded to new

At the November meeting of the Pharmaceutical Benefits Advisory Committee (PBAC), two new medications for the treatment of

A new study published this week in the prestigious journal JAMAconfirms that vaccination for human papillomavirus (HPV) does

MS Research Australia is honoured to be selected as a finalist in the prestigious Fundraising Institute Australia (FIA)

A team of international researchers, including eminent Australian researcher Professor Claude Bernard from Monash University, has recently identified

MS Research Australia has welcomed the Federal Government’s re-commitment to the $20 billion Medical Research Future Fund (MRFF)

In a media release issued on 1 December, pharmaceutical company Novartis, the makers of Gilenya (fingolimod), have announced

Imagine a cat’s cradle – a network of threads running to and fro, crossing over and diverging again